GENEVA - Swiss drugmaker Roche Holding AG said Friday it has granted a sublicense to an Indian pharmaceutical maker to produce the antiviral drug Tamiflu, the medicine believed to be the most efficient treatment for the human version of the bird-flu virus.
The deal allows Hetero Drugs to produce a generic version of Tamiflu for developing countries seeking to stockpile the drug in case of a flu pandemic, Roche said in a statement.
Bird flu has killed at least 71 people in Asia since 2003.
